Cite
HARVARD Citation
Suzuki, Y. et al. (n.d.). Circulating Interleukin 6 and Albumin, and Infliximab Levels Are Good Predictors of Recovering Efficacy After Dose Escalation Infliximab Therapy in Patients with Loss of Response to Treatment for Crohn's Disease. Inflammatory bowel diseases. 21 (9), p. . [Online].